Literature DB >> 6861925

Nuclear DNA in carcinoid tumours of the lung.

T Blöndal, T Arnorsson, A Bengtsson, E Wilander.   

Abstract

Fluorescence cytophotometric DNA measurements on 15 carcinoid tumours generally yielded histograms with a prominent G1-phase peak and only low frequencies of S- and G2-phase nuclei. In 13 tumours the modal DNA value was near diploid (1.75-2.25). Three of these 15 tumours showed a much greater number of S- and G2-phase values than the others and in two of them there were also G1-phase peaks below the near-diploid range. Among 22 samples of small cell carcinoma of the lung (SCCL), the modal DNA value was hypodiploid in two, near diploid in seven and hyperdiploid in 13. The proportion of S-phase cells was higher in the SCCL samples than in the carcinoid tumours. It is suggested that the nuclear DNA distribution profile may facilitate morphological discrimination of a classical pulmonary carcinoid from small cell carcinoma. In a borderline case, the finding of a hyperdiploid DNA stem line and high proliferative activity will favour the diagnosis of SCCL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861925

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  4 in total

Review 1.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

2.  Nuclear DNA content in 27 pancreatic endocrine tumours: correlation with malignancy, survival and expression of glycoprotein hormone alpha chain.

Authors:  C Donow; H Baisch; P U Heitz; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  DNA ploidy in bronchopulmonary carcinoid tumours.

Authors:  D J Jones; P S Hasleton; M Moore
Journal:  Thorax       Date:  1988-03       Impact factor: 9.139

4.  Joint meeting of the British and European Associations for Cancer Research and the Royal Society of Medicine (Section of Oncology). November 3-5, 1986, London. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.